In this podcast, CEO David Trainer talks about the Valeant-Allergan deal and the various advantages that influential Wall Streeters like Bill Ackman have over the individual investor. Don’t worry though: He’ll also talk about what things you can focus on to generate low-risk, high-reward investment returns.

Listen below:

Photo credit:

Leave a Reply

Your email address will not be published.